The National Agency for Food and Drug Administration and Control has again denied the approval of PacHerbal Products for treating the symptoms of the coronavirus.
The Office of the Director-General, NAFDAC, in a statement published on the 11th of July 2020 via their twitter page, said: “The statement circulating on social media that NAFDAC has approved Paxherbal products specifically for treating symptoms associated with Coronavirus is WRONG and INACCURATE”.
“Until a clinical study is done in a scientific manner, no herbal medicine manufacturer can claim effectiveness to treat COVID19 associated symptoms”, the office buttressed.
This denial by NAFDAC’s Director-General is the second of its type in the past few months.
The first one came up in May 2020 when Pax Herbal Clinic, in a Facebook Post, had claimed to be working with NAFDAC to speed up the approval of the use of one of their products for the treatment of Covid-19.
Responding to the above claim, Prof. Mojisola Adeyeye, the Director-General of NAFDAC, had reacted by releasing a statement that mentioned that Pax CVD Plus, the PacHerbal Product, has not been registered or listed for treatment of COVD-19.
In a press release released at the tat time, she stated that ” NAFDAC wishes to inform the public that Pax CVD Plus has not been registered or listed for treatment of COVD-19; neither have we registered nor listed any other remedy for COVID-19. The clinical trial has not taken place. Therefore, it is unfortunate that Pax Herbal has made claims that are not backed up by facts.”
The response was intended to set the record straight, she said.
The second and most recent denial occurred when NAFDAC announced the processing of Twenty-One (21) herbal medicinal products for “safe to use” or listing status.
The DG said: “Many of the applicants claim that their products are immune boosters and anti-infectives useful for relief of symptoms that could be associated with #COVID19. However, no clinical study has been done yet on any of the products to prove their claim of efficacy.”
“Listing status involves the review of the composition of the formulation, the labelling of the product, the process of manufacture, and “Safe to use” testing.”
One such product that was listed as safe to use as an immune booster and anti-infective is the Pax Herbal Cugzin Capsule 290mg. However, it has not been approved for treating symptoms of the coronavirus.
RUGIPO Fixes Date For Mid-semester Test
The management of Rufus Giwa polytechnic, Owo, (RUGIPO) has announced that the 2019/2020 session’s mid-semester test will be taken between…
AMHEC Holds 1st Africa Mental Health Reforms Campaign
The African Mental Health Consortium, AMHEC organised a mental health reform campaign, which was held virtually on Zoom on Friday…